Strata Skin Sciences Price to Sales Ratio 2010-2024 | SSKN
Historical PS ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The current P/S ratio for Strata Skin Sciences as of March 11, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Strata Skin Sciences P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-03-11 | 2.60 | 0.29 | |
| 2024-09-30 | 2.75 | $9.00 | 0.31 |
| 2024-06-30 | 3.07 | $9.36 | 0.33 |
| 2024-03-31 | 3.78 | $9.32 | 0.41 |
| 2023-12-31 | 5.50 | $9.56 | 0.58 |
| 2023-09-30 | 5.95 | $10.13 | 0.59 |
| 2023-06-30 | 9.50 | $10.30 | 0.92 |
| 2023-03-31 | 10.59 | $10.56 | 1.00 |
| 2022-12-31 | 7.90 | $10.42 | 0.76 |
| 2022-09-30 | 8.71 | $10.02 | 0.87 |
| 2022-06-30 | 9.61 | $9.57 | 1.00 |
| 2022-03-31 | 14.70 | $9.10 | 1.62 |
| 2021-12-31 | 14.65 | $8.79 | 1.67 |
| 2021-09-30 | 18.40 | $8.13 | 2.26 |
| 2021-06-30 | 15.60 | $7.54 | 2.07 |
| 2021-03-31 | 16.70 | $6.58 | 2.54 |
| 2020-12-31 | 15.00 | $6.89 | 2.18 |
| 2020-09-30 | 13.50 | $7.67 | 1.76 |
| 2020-06-30 | 11.50 | $8.28 | 1.39 |
| 2020-03-31 | 9.50 | $9.55 | 0.99 |
| 2019-12-31 | 20.80 | $9.96 | 2.09 |
| 2019-09-30 | 21.50 | $11.26 | 1.91 |
| 2019-06-30 | 24.90 | $11.57 | 2.15 |
| 2019-03-31 | 28.50 | $14.48 | 1.97 |
| 2018-12-31 | 26.00 | $27.46 | 0.95 |
| 2018-09-30 | 35.40 | $56.21 | 0.63 |
| 2018-06-30 | 20.50 | $83.02 | 0.25 |
| 2018-03-31 | 11.70 | $114.05 | 0.10 |
| 2017-12-31 | 12.30 | $131.23 | 0.09 |
| 2017-09-30 | 17.70 | $131.13 | 0.13 |
| 2017-06-30 | 24.30 | $138.10 | 0.18 |
| 2017-03-31 | 30.25 | $135.18 | 0.22 |
| 2016-12-31 | 22.00 | $131.21 | 0.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.011B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Enovis (ENOV) | United States | $2.475B | 16.49 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.072B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |